Amoeba (LTS:0RAE) Valuation Rank


LTS:0RAE Amoeba SA LTS:0RAE
28 GF Score
Price €0.76
! 3 Warning Signs
View Full Analysis

What is Amoeba Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Amoeba Valuation Rank Related Terms

LTS:0RAE
28GF Score
Amoeba SA LTS:0RAE
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amoeba Business Description

Other Exchanges ALMIB:FranceA1H:Germany
Address 38 Avenue des Freres Montgolfier, Chassieu, Lyon, FRA, 69680
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
28GF Score

Get the complete analysis for LTS:0RAE

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price